Objective: The purpose of the current study was to investigate the feasibility of applying defect-size femoral implants for the treatment of localized cartilage defects in a 1-year follow-up model.
Introduction
Localized cartilage defects in the knee are associated with disability and symptoms such as joint pain, locking phenomena and reduced or disturbed function. Moreover, these defects predispose to severe forms of osteoarthritis 1 . The surgical treatment of localized cartilage defects is usually aimed at stimulation of biological repair, including subchondral perforation 2, 3 , osteochondral transplantation, and autologous chondrocyte transplantation. Although these biological repair treatment modalities are well established 4, 5 , they have limitations. Often, fibrous or fibrocartilaginous tissue is formed, which is frequently followed by progressive joint degeneration, often resulting in an indication for further surgical intervention, such as an osteotomy, joint distraction 1 , a hemiarthroplasty or a total joint replacement 1 . A proposed alternative for the treatment of localized (osteo)chondral defects is the use of defect-size metal implants filling the cartilage defect, thereby re-establishing the integrity of the joint surface. Although this treatment modality has already been applied in humans after trauma of the knee, hip, toe and shoulder 6e8 , there is no experimental evidence suggesting its efficacy as an alternative to the established surgical treatments. In fact, in a rabbit model, defect-sized implants inserted in knee defects were found to induce considerable cartilage degeneration of the opposing articulating cartilage of the tibia 9, 10 . However, this may have been due to the sensitivity of such a small animal model to small deviations in surgery procedures. The thickness of healthy adult rabbit knee cartilage thickness is 0.3 mm, whereas healthy goat knee cartilage is 0.7e1.5 mm thick 11 . Thus malpositioning of only 1 mm or less might have fewer consequences in a goat knee.
Vital in the application of non-degradable implants are their biomechanical and wear characteristics. Currently, cobaltechromium (CoCr) alloy is a frequently employed material for hemiarthroplasty bearing surfaces, however, even given the wide implementation, some downsides are described 12, 13 . For example, failure of CoCr hemiarthroplasty hip prostheses was found, due to pain and erosion of acetabular articular cartilage and bone 14 . Therefore, ceramic bearing materials such as oxidized zirconium (OxZr) have sparked renewed interest, based on in vivo properties such as better scratch resistance, less surface roughness after articulation against third body debris such as bone cement, a lower friction coefficient and more elasticity, while maintaining equivalent device fatigue strength 15e21 . Therefore, it could be hypothesized that this material would be suitable as an articulating surface in treatment of cartilage defects, joint trauma and early, localized osteoarthritis using defect-sized non-degradable implants. However, the postulated superiority of this material has not been proven in vivo, where not only articulation, but also osseointegration and surgical aspects define the functionality of an implant. To verify the applicability of local implants in the treatment of cartilage defects in a large animal model (in an effort to avoid the propensity of small animal models for suboptimal implant positioning) and to evaluate whether OxZr would confer an advantage over CoCr in terms of joint and cartilage integrity and implant fixation, we used an in vivo model in which a femoral tack (similar to the abovementioned rabbit studies) of either material was applied to a localized defect in a goat knee joint.
Materials and methods

EXPERIMENTAL DESIGN
This research was approved by the Institutional Animal Care Committee of the Utrecht University (approval number DEC04.07.057). In thirteen adult female Dutch milk goats, a standardized medial femoral condyle defect was created in both knees. The defects were randomly treated with either an OxZr (nine knees) or CoCr (nine knees) press fit implant (:articulating surface 5.0 mm; length 13.5 mm) or left untreated (eight knees). As a control group, the un-operated left knees of six goats (six knees) included in a separate study were used. The experimental animals were killed 52 weeks after surgery. Macroscopic articular evaluation was performed immediately before creating the defect and 52 weeks after treatment. Tibial and femoral cartilage quality was evaluated by macroscopic, microscopic, and by biochemical analysis. After 52 weeks, implant osseointegration was measured by automated histomorphometry and defect healing of the untreated defects was scored microscopically. All results are described as mean AE standard deviation.
ANIMALS
Thirteen adult female Dutch milk goats, aged 3.1 AE 0.28 years and weighing 66.4 AE 8.7 kg were used for surgery. The un-operated left knees of six adult female Dutch milk goats aged 2.4 AE 0.28 years and weighing 65.6 AE 5.7 kg were used as a control group. These goats were used in a separate (unpublished) study (approval number DEC04.07.057). The number of animals needed for this study was determined by a power analysis. The power was 0.8 and a was 0.05. The data used for this analysis were obtained from biochemical analysis as described previously 22 . Food and water was given ad libitum. General health and care conditions were monitored by the laboratory animal welfare officer.
IMPLANTS
Implants were custom-manufactured to our design specifications by Smith & Nephew (Memphis, TN, USA). The size of the implant was 13.5 mm (length) by 5.0 mm (diameter-articulating surface). The articulating shape of the implant was designed after a study on goat cadaver knees and tested in a pilot study [ Fig. 1(A, B) ].
SURGERY
After acclimatizing for at least 3 weeks in the animal care facility, 1 day prior to surgery, a topical fentanyl application bandage was given as pain medication. The goats were weighed pre-operatively. Surgery was performed on both knees, under general inhalation anaesthesia using an isoflurane (2% in air) gas mixture (Abbott Laboratories, ASTPharma, The Netherlands) preceded by detomidine hydrochloride sedation (Pfizer, The Netherlands) and antibiotic prophylaxis (Augmentin Ò , GlaxoSmithKline, United Kingdom). All surgical procedures were carried out under aseptic conditions and by the same surgeon (RC), who had gained specific experience in the course of a pilot study. The medial femoral condyle was exposed through a medial parapatellar incision, without dislocating the patella. After inspecting the joint and determining the location for implantation, a drill (diameter 5.0 mm) was used to create a standardized full-thickness cartilage defect not penetrating the subchondral bone layer (2.0 mm deep). To place the implant, the defect was drilled deeper (3.0 mm) and subsequently, the implant was placed flush to the surrounding cartilage surface by tapping the implant into place using a specially designed tamp with a polyethylene head, as previously described 9, 10 . After insertion, the implants were visually inspected and manually tested for fixation. Following lavage, the joint, subcutis and skin were closed in three layers using sutures. Additional post-operative pain relief was provided by buprenorphin (ScheringePlough, The Netherlands). Until 5 days post-operatively, ampicillin (Albipen Ò , Intervet, The Netherlands) was given. Post-operatively, the goats Fig. 1 
.
RADIOGRAPHS
Pre-operatively, fluoroscopy was applied in an anterioreposterior and a mediolateral direction to confirm the normal anatomy and the size of the bone. Immediately post-surgery, the positioning of each implant was visualised and possible surgical complications such as fractures were examined. After sacrifice of the animals (52 weeks), the joints were checked for implant malpositioning (depressed or elevated compared to the surrounding cartilage), loosening (sclerotic zones and radiolucency surrounding the implant), and movement from the original position, or other complications (such as fractures).
GENERAL MACROSCOPIC ARTICULAR EVALUATION
After opening of the joint space prior to creation of the defects (¼healthy joint) and application of the treatments, as well as post-mortem, the joint was inspected blinded to the animal and treatment and evaluated by two observers (RC & MvR) according to the guidelines as described by O'Driscoll 23e25 . Since it was not possible to score the 'restoration of contour' and 'cartilage erosion of the graft' for the implant groups, the Macroscopic Articular Evaluation Parameters were modified (scores 0e6 instead of 0e10) ( Table I) .
MACROSCOPIC SCORING OF ARTICULAR CARTILAGE COMPARTMENTS
After removal of soft tissues, macroscopic evaluation as described by Mastbergen et al. 26 was performed by two observers (RC & MvR) on coded high-resolution photographs for each compartment separately (blinded to the source of the photograph, the medial plateau, directly in contact with the defect/implant and the lateral plateau and condyle, as part of the knee joint, but not directly in contact with the defect/implant). This scoring system evaluates the cartilage surface (Table II) . The scores of the two observers were averaged and outliers with a difference of more than one point were scored again, until consensus was reached. The higher the score, the more the cartilage is damaged.
CARTILAGE EXPLANTS HARVEST
Upon sacrifice, cartilage tissue samples were obtained from predefined locations under aseptic conditions (Fig. 2) . First, two full-thickness cartilage tissue explants were cut from the underlying subchondral bone layer, one just anterior and one just posterior from the most weight-bearing area of each femoral condyle and tibial plateau. Subsequently, each cartilage explant was cut into three or five separate pieces (depending on location), of which two or four were used for biochemical assays, respectively. One piece was used for histology (the most peripheral one). Furthermore, full cross-sectional osteochondral explants were harvested for histology from the middle of each location (medial and lateral tibial plateau, and medial and lateral femoral condyle), including the defect area or containing the implant.
MICROSCOPIC CARTILAGE EVALUATION
Immediately after harvesting, all tissue explants used for microscopic analysis were fixed in 10% buffered formalin during 48 h. Subsequently, all osteochondral tissue explants were decalcified using Luthra's solution (3.2% 11 M HCl, 10% formic acid in distilled water) over 48 h. Non-decalcified and decalcified tissues were then dehydrated via 70%e100% ethanol, immersed in xylene and embedded in paraffin. Embedded tissues were cut into 5 mm thick paraffin sections and stained with Safranin-O and fast green according to the Osteoarthritis Research Society International (OARSI) guidelines 27 . The histological sections were blinded and presented at random to two observers (RC & MvR).
Osteochondral sections from the entire lateral femoral condyle and the tibial plateau from medial to lateral were evaluated using the OARSI Osteoarthrtis Cartilage Histopathology Assessment System (OOCHAS) 27, 28 to determine the degree of cartilage degeneration for each location separately. A score of 0 represents normal cartilage, whereas a score of 24 represents (Table III) . These decalcified sections were also scored for the degree of filling of the untreated cartilage defects, blinded, at random by two different observers (RC & MvR) using the criteria suggested by O'Driscoll 23, 24 (Table IV) . In addition, the Histological/Histochemical Grading System (HHGS) 29 was applied to the non-decalcified cartilage explants. Since in the latter explants bone was not included, the tidemark between cartilage and bone was not present. Moreover, due to the dissection method, pannus could not be demonstrated on the cartilage explants. Therefore, the maximum score that could be obtained was 11 instead of the 14, due to the omission of criteria 'pannus', 'clefts to calcified zone', and 'tidemark crossed by blood vessels' as described previously 30 (Table V) .
BIOCHEMICAL CARTILAGE EVALUATION
For femoral condyles and tibial plateaus, cartilage proteoglycan (PG) content, synthesis, and release were determined of respectively eight and 16 explants obtained from predefined locations. Two to four full-thickness cartilage slices, anterior and posterior from the most weight-bearing area, were weighed aseptically (range 5e20 mg) and cultured individually in 96-well round-bottom microtiter plates. Explants were cultured in Dulbecco's Modified Eagle Medium (DMEM; Gibco 074-01600, 0.81 mM SO 4 2À , 24 mM NaHCO 3 ) supplemented with ascorbic acid (85 mM), glutamine (2 mM), penicillin (100 IU/ml), streptomycin sulfate (100 mg/ml), and 10% pooled goat serum at 5%CO 2 , and 37 C (all from: Gibco, New York, USA). Ex vivo PG synthesis was determined at day 0 by measuring 35 SO 4 2À incorporation and implants were incubated for a subsequent 3-day period in the absence of label to determine PG release and PG content. Conditioned medium and cartilage samples were stored at À20 C until analysis. , the samples were washed three times for 45 min in fresh culture medium (37 C) and cultured for another 3 days. Conditioned medium was collected and frozen at À20 C until analysis. Cartilage samples were digested in 3% papain buffer (dissolved in 0.5 M phosphate buffer, 20 mM N-acetylcysteine and 20 mM Na 2 -EDTA, pH6.5) at 65 C for 2 h. Papain digests were diluted to the appropriate concentrations for analysis of PG synthesis rate and PG content/release as well as DNA content. 35 
PG CONTENT AND RELEASE
Alcian Blue (A-5268; Sigma) precipitation of GAGs in the papain digests and conditioned medium was determined as a parameter for total PG Table IIIA OARSI Osteoarthritis Cartilage Histopathology Assessment System e Advanced grading methodology-as described by Pritzker et al. 25, 26 First, the grade is determined, then the stage, and finally, the grade is multiplied by the stage resulting in the final score content and release, respectively. Staining for GAG was measured as the change in absorbance at 620 nm using chondroitin sulphate (C4383; Sigma-Aldrich, The Netherlands) as a reference. Results are expressed as mg GAG per gram wet weight of the cartilage explants and the initial GAG content on day 0 was calculated from the total amount of GAG released into the medium and the total GAG content of the explants after 72 h.
EVALUATION OF BIOCOMPATIBILITY AND OSSEOINTEGRATION
After 48 h of fixation in 10% buffered formalin, medial femoral condyle tissue slices containing the implants were dehydrated via 70e100% ethanol, and embedded in polymethylmethacrylate. Approximately 10e20 mm thick sections were sawed in a longitudinal direction through the middle of the implant using the Leica Ò SP1600 Saw Microtome system and subsequently stained with methylene blue/basic fuchsin. Histomorphometry was performed with a personal computer (PC)-based system equipped with the KS400 version 3.0 software (Carl Zeiss Vision, Germany) as described previously 9, 10 . In short, the percentage of bone surrounding the implant within a fixed distance from the implant surface was calculated and the percentage of the implant circumference in contact with bone was determined.
STATISTICAL ANALYSIS
Values are given as mean and standard deviation. Since there was more than one tissue sample analyzed per location for the histological and biochemical analysis, the mean of those scores per location were used as one statistical unit. For the macroscopic scoring of articular cartilage compartments, a general linear model with repeated measurements was performed. For the analysis of the general macroscopic articular evaluation, the histologic and biochemical cartilage scores, each treatment group was analyzed separately, using a general linear model with repeated measurements and a split file layered by group since there was an interaction between the treatment group and location. For the differences between the treatment groups per location, a one-way analysis of variance (one-way AN-OVA) was performed. For the analysis of the histomorphometry a paired Student's t-test was performed since an intra-animal comparison could be made. All results were corrected for multiple testing using a Bonferroni-correction, for each analysis separately. For all analyses, P < 0.05 was defined as statistical significant difference.
Results
SURGERY AND ANIMAL HEALTH
Pre-operatively, fluoroscopy confirmed normal knee joint anatomy for all goats. Surgery was performed with one major complication: one goat developed an intra-articular infection surrounding a CoCr implant and was euthanized after 3.5 months. This goat (CoCr and OxZr implant) was excluded from further analysis. All other goats were able to load their limbs and move the knees without any limitations. The goats showed a maximal weight loss (at the lowest level) of 5.5 AE 1.3% (n ¼ 12) after surgery. At the end of the 52-weeks follow-up period, all implants were mechanically stable and were located in their original position (Fig. 3) . Fluoroscopy showed no signs of malpositioning, loosening or other complications (Fig. 4) .
GENERAL MACROSCOPIC ARTICULAR EVALUATION
The pre-operative scores did not differ from the un-operated healthy knee joints (Fig. 5) . Upon sacrifice, 52 weeks after creating the defect or inserting the implants, the scores had decreased significantly in all three operated groups compared to pre-operative and the un-operated healthy knee joints. The reduced scores resulted from some decrease in range of motion, minor intra-articular fibrosis and an opaque cartilage appearance. No differences were observed between the untreated defects and defects treated with either implant.
MACROSCOPIC EVALUATION OF ARTICULAR COMPARTMENTS
Fifty-two weeks after surgery, the knees with untreated defects, OxZr and CoCr implants had higher macroscopic scores (ranging from fibrillated with shallow grooves to deep sharp grooves) at the medial tibial plateau compared to the healthy knee joints (Fig. 6) . The lateral compartment (lateral tibial plateau and lateral femoral condyle) was only slightly fibrillated for all groups. In the knees treated with a CoCr implant, degeneration of the lateral plateau was more pronounced compared to the untreated control knees. As determined by the Cartilage Repair Score, the healing of the untreated defects was only partly achieved [ Fig. 7(A) ]. The average score was 13.3 AE 3.0 (n ¼ 8) out of the maximum of 24 points.
MICROSCOPIC CARTILAGE EVALUATION
According to the OOCHAS scores of the osteochondral samples, all compartments showed slight (intact surface with hypertrophy and/or oedema) to moderate (simple to complex fissures with PG washout) cartilage degeneration (Fig. 8) . In general, the lower scores included mild PG washout and minor fissures, whereas the higher scores included moderate PG washout (i.e., less intense Safranin-O staining) and moderate fissures. Fibrillations were rarely seen. The medial tibial plateau was significantly more degenerated after articulating against the untreated defect or either implant compared to the un-operated healthy knee joints (Fig. 9) . The OOCHAS scores did not differ significantly between treated and untreated defects for cartilage of the lateral tibial plateau and the lateral femoral condyle.
Analysis of the HHGS scores of the cartilage samples taken from locations anterior and posterior from the most weight-bearing area of all cartilage surfaces revealed that all compartments showed slight degeneration (surface irregularities with slight reduction of Safranin-O staining) without differences between treatments (Fig. 10) .
PG CONTENT AND RELEASE
The GAG content (in mg/mg of wet weight) at the medial tibial plateau and the lateral femoral condyle was higher in cartilage explants harvested from knees with untreated defects and either implant compared to the healthy un-operated joints [ Fig. 11(A) ]. No differences were seen at the Fig. 5 . The modified Macroscopic Articular Evaluation Parameters (mean AE standard deviation). A score of six represents a healthy joint, whereas a score of 0 represents a severely degenerated, fibrillated, and fixated knee joint. The un-operated joints (long dashed line) are considered the healthy joints. The mean score of the joints immediately before creating the defect represents the pre-operative value (long line). The mean score of the modified Macroscopic Articular Evaluation Parameters was 5.8 AE 0.4 (n ¼ 6) for the un-operated healthy joints and 5.7 AE 0.5 (n ¼ 24) pre-operatively for the operated knee joints (untreated defect, OxZr, and CoCr) (P ¼ 0.44). Upon sacrifice, 52 weeks after creating the defect or inserting the implants, the scores had decreased significantly for all three operated groups to 4.4 AE 0.5 (n ¼ 8) for the untreated defects (P ¼ 0.009); 4.1 AE 0.8 (n ¼ 8) for the OxZr implants (P ¼ 0.009); 4.1 AE 0.8 (n ¼ 8) for the CoCr implants (P ¼ 0.015). No differences were observed between the untreated defects and defects treated with either implant (vs OxZr P ¼ 0.48; vs CoCr P ¼ 0.66). Fig. 6 . Macroscopic cartilage score 52 weeks after surgery (mean -AE standard deviation). The scores of the un-operated knee joints (n ¼ 6) are represented by the white bars (control). 52 weeks after surgery, the untreated defects (n ¼ 8), OxZr (n ¼ 8) and CoCr (n ¼ 8) implants had higher scores (ranging from fibrillated with shallow grooves to deep sharp grooves) at the medial tibial plateau compared to the untreated healthy knee joints (* control vs untreated defect P ¼ 0.032, vs OxZr P < 0.001, vs CoCr P ¼ 0.002). The lateral compartment (lateral tibial plateau and lateral femoral condyle) was only slightly fibrillated for all groups. The lateral plateau was more degenerated after inserting a CoCr implant compared to the untreated control knees (* P ¼ 0.01) 
other locations in the joint. GAG release (in %) after these 72 h of culturing was significantly higher at the lateral tibial plateau and the medial femoral condyle in the untreated defects and either implant compared to the healthy un-operated joints [ Fig. 11(B) ]. No differences were seen at the other locations in the joint.
METABOLIC CARTILAGE ACTIVITY 35 SO 4 2À incorporation showed significantly less incorporation at the lateral tibial plateau and the medial femoral condyle for the untreated defects and either implant compared to the un-operated healthy joints [ Fig. 11(C) ]. The other locations did not show any differences between treatments.
BIOCOMPATIBILITY AND OSSEOINTEGRATION
Two implants had subsided (1 Â OxZr and 1 Â CoCr) and were surrounded partly by bone and fibrous cartilaginous tissue. All other implants were firmly fixed in the bone [ Fig. 7(B, C) ]. Inflammatory responses were not seen (Fig. 12) .
Discussion
This study shows that the cartilage degeneration caused by a critical size untreated cartilage defect in the knee joint could not be prevented by our application of small OxZr and CoCr implants into these cartilage defects. This was illustrated both macroscopically and microscopically. Macroscopic joint evaluation demonstrated an increase of joint degeneration after either surgery, regardless whether the created defects were treated by either implant or not at all. Similar results were seen in the macroscopic cartilage surface scores, where the medial tibial plateau, directly articulating against the untreated defect or the implants, was significantly degenerated. This was also confirmed by histology of cartilage explants from the most weight-bearing area of the medial tibial plateau. Histology from locations more anterior and posterior from the most weight-bearing area of all cartilage surfaces did not show any differences between the operated and non-operated joints. Furthermore, the lateral compartment was slightly degenerated as well, albeit less than the medial compartment. This gradual decrease in cartilage quality of adjacent areas was found before 9, 10 and may be due to generalised intra-articular changes occurring as a consequence of local damage and negatively affecting more remote areas 22 . . OOCHAS microscopic score of osteochondral tissue explants (mean AE standard deviation). The score of 0 represents normal cartilage, whereas a score of 24 represents a severely degenerated joint surface. All operated knees joints (n ¼ 24) showed higher scores compared to the un-operated (control) group (n ¼ 6) at the medial tibial plateau, represented by * (control vs untreated defect P ¼ 0.032, vs OxZr P ¼ 0.023, vs CoCr P ¼ 0.045). The lateral compartment also showed mild degeneration, however, this was similar to the un-operated (control) group (all P > 0.05).
Although macroscopical and microscopical analyses revealed distinct signs of cartilage degeneration, the biochemical data on PG turnover were inconclusive, maybe because of biochemical variety within a single joint, due to different cartilage thickness and loading. In line with the macroscopic and microscopic results, cartilage degradation in the knees with treated and untreated defects was higher and synthetic activity was lower compared to un-operated knees. However, the GAG content was higher at the medial tibial plateau and the lateral femoral condyle of the untreated defects and either implant compared to the un-operated control knees.
Two of the sixteen analyzed implants were surrounded by fibrocartilaginous tissue, showed a subsidence and had only a very limited amount of bone-implant contact (3e5%). The other thirteen implants showed a good osseointegration and high bone-implant contact (40e60%). Previously, rabbit studies showed similar bone-implant contact percentages ranging from 36 AE 4% 31 to 47.5 AE 4.7% 9 and 63.2 AE 3.2% 10 . This study was designed to evaluate the long-term effects of treating a localized ''fresh'' cartilage defect in the knee joint with a small metal implant. However, it has been described that a disturbed intra-articular environment, caused by one or more cartilage defects, negatively influences cartilage repair 30 . Recently, we published a goat study were the same OxZr implants were compared to microfracture in an established defect model 32 . A cartilage defect was created and after 10 weeks treated with either an OxZr implant or microfracturing with a follow-up period of 6 months. Both microfracture and the use of implants caused significant degeneration in the directly articulating cartilage as well as in more remote sites in the knee. However, metal implants caused less damage to the articulating cartilage than the marrow stimulation/microfracturing technique. To what extent this is due to the shorter follow-up or the immediate treatment of the defect is not clear. The investigators of another goat study concerning similarly shaped implants concluded that the extent of the tissue damage was proportional to any elevation of the prosthesis above the adjacent cartilage surface 33 . They used an implant system that ensured accurate positioning of the implant, using custommade implants shape-matched to the adjacent articular contour (measured at five locations). Although these authors proposed positioning the surface of the prosthesis with its entire perimeter sunken 1 mm below the adjacent cartilage surface, we previously found in a rabbit study that positioning the implant flush induces less tibial cartilage damage compared to placing them 1 mm below the surrounding cartilage surface 9 . Another in vitro study showed that elevated implantation results in increased peak contact pressure and might be biomechanical disadvantageous in an in vivo application 34 . Altogether, this importance of implant placement has implications for surgical practice, where precision is highly dependent on the individual surgeon's skills and experience. The implants used in the rabbit 9 and the current goat study are relatively small compared to the size of the implants used in the former goat study 33 . It is possible that smaller implants load more focally than a larger implant and should therefore be placed flush, whereas a larger implant does not. Currently, only few studies are available about clinical application of metal implants used for cartilage replacement 35, 36 . The drawback of performing surgery on both knees is that the treatment of one knee might influence the outcome of the treatment of the contralateral knee. However, the intra-animal comparison results in fewer animals needed for the study. No sham-operated animals without defects were included in the study. However, previous rabbit and larger osteoarthritis (OA) model studies including sham-operated animal groups did not reveal any cartilage damage, even at shorter time intervals, suggesting that this is not likely to be a confounder in the current study 37e39 . As controls, un-operated knees were included in this study. Due to ethical considerations, these knees were obtained from goats that were used in a separate study where the medial tibial plateau of the contralateral knee was replaced by a CoCr implant. Therefore, this implant might have affected the quality of the analyzed contralateral 'healthy' knee due to increased weight bearing. However, by macroscopic articular evaluation, no evidence of difference was found for the un-operated control knees compared with the knees about to receive untreated defects or implant treatment. Moreover, any increased weight bearing for the un-operated knees used as controls in this study would have yielded worse rather than better cartilage quality compared to cartilage from completely untreated animals. Fig. 10 . HHGS microscopic scores of cartilage explants taken from locations anterior and posterior from the most weight-bearing area of all cartilage surfaces (mean AE standard deviation). There were no differences between the untreated healthy (control) knees (n ¼ 6) and the operated knees 52 weeks after the creation of a defect (n ¼ 8) or inserting an OxZr (n ¼ 8) or CoCr (n ¼ 8) implant (all P > 0.05). Fig. 11 . GAG content (A), release (B), and synthesis (C) of explants taken from locations anterior and posterior from the most weight-bearing area (mean AE standard deviation). Swelling is one of the first features in cartilage degeneration, indicating collagen damage. In turn this leads to a loss of tensile properties and to a loss of PGs (i.e., lower PG content, higher release), which is accompanied by an attempt to repair the cartilage (i.e., increased synthesis). (A) At the medial tibial plateau and the lateral femoral condyle, a significantly lower GAG content (represented by *) was measured (medial tibial plateau: control (n ¼ 6) vs untreated defect P ¼ 0.080 (n ¼ 8); vs OxZr P ¼ 0.012 (n ¼ 8); vs CoCr P ¼ 0.003 (n ¼ 8)); lateral femoral condyl: control (n ¼ 6) vs untreated defect P ¼ 0.001 (n ¼ 8); vs OxZr P ¼ 0.012 (n ¼ 8); vs CoCr P ¼ 0.010 (n ¼ 8); No differences were seen at other locations in the joint. (B) At the lateral tibial plateau and the medial femoral condyle, a significantly lower GAG release was measured in the un-operated healthy knee joints compared to the untreated defect and either implant (* lateral tibial plateau: control (n ¼ 6) vs untreated defect P ¼ 0.010 (n ¼ 8); vs OxZr P ¼ 0.002 (n ¼ 8); vs CoCr P ¼ 0.023 (n ¼ 8); medial femoral condyle: control (n ¼ 6) vs untreated defect P ¼ 0.001 (n ¼ 8); vs OxZr P < 0.0001 (n ¼ 8); vs CoCr P ¼ 0.018 (n ¼ 8)). No differences were seen at the other locations in the joint. (C) At the lateral tibial plateau and the medial femoral condyle, a significantly higher 35 SO 4 2À incorporation (represented by *) was measured in the un-operated healthy knee joints compared to the untreated defect and either implant (lateral tibial plateau: control (n ¼ 6) vs untreated defect P ¼ 0. 
Conclusions
Altogether, considerable cartilage degeneration was induced in the articulating cartilage 1 year after creating a cartilage defect in the medial femoral condyle. Inserting a small metal implant in this defect, made of either CoCr or OxZr, could not prevent this degeneration. Therefore, further development and fine-tuning of the application of defect-size implants is required to make this the therapy of choice for the long-term treatment of local cartilage defects.
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